Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Certa Dose
AddedFeb 15, 2024
UpdatedJun 18, 2026
Certa Dose

Certa Dose

Seed

Certa Dose: FDA-cleared medical device firm offering color-confirmed, accurate dosing solutions for pediatric care.

HQ
Denver, CO, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Certa Dose, founded with a mission to enhance pediatric care through precise medication dosing, offers innovative medical devices that utilize color confirmation for accurate administration. Their flagship product, an FDA-cleared syringe, is designed for the administration of epinephrine to pediatric patients. This syringe features color zones aligned with the Broselow pediatric color-coding system, aiding clinicians in delivering the correct dose swiftly and accurately during emergencies.

Notable affiliations include a contract with Vizient, a leading healthcare performance improvement company. Certa Dose's key achievements include FDA clearance for their syringe and recognition for innovation in medical technology. By improving dosing accuracy in critical situations, Certa Dose has significantly impacted pediatric emergency care, potentially reducing medication errors and enhancing patient safety.

Certa Dose - Similar Companies

DoseCue logo

DoseCue

Solution Medical logo

Solution Medical

Certintell logo

Certintell

certintell.com

Remedease logo

Remedease

remedease.com

EveryDose logo

EveryDose

everydose.ai

Diavibe logo

Diavibe

CarrTech logo

CarrTech

carrtechcorp.com

SafeShot Technologies logo

SafeShot Technologies

Compact Medical logo

Compact Medical

Genixus logo

Genixus

Emergency Medical Innovation logo

Emergency Medical Innovation

JetMeds logo

JetMeds

jetmeds.io

Innovative Trauma Care logo

Innovative Trauma Care

Credence MedSystems logo

Credence MedSystems

Equashield logo

Equashield

equashield.com

Certa Dose - Quick Facts

Who are Certa Dose's competitors?

Companies similar to Certa Dose include DoseCue, Solution Medical, Certintell and Remedease.

When was Certa Dose founded?

Certa Dose was founded in 2013.

Where is Certa Dose's headquarters located?

Certa Dose's headquarters is located in Denver, CO, US.

When was Certa Dose's last funding round?

Certa Dose's most recent funding round was for $2.6M (USD) in July 2018.

How much has Certa Dose raised to-date?

As of Jul 17, 2018, Certa Dose has raised a total of $8.7M (USD).

How many employees does Certa Dose have?

Certa Dose has 30 employees as of Feb 5, 2024.

Certa Dose - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Medical
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified